Townsquare Capital LLC Has $1.83 Million Stake in HealthEquity, Inc. (NASDAQ:HQY)

Townsquare Capital LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 3.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,292 shares of the company’s stock after buying an additional 839 shares during the period. Townsquare Capital LLC’s holdings in HealthEquity were worth $1,825,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. GSA Capital Partners LLP acquired a new stake in shares of HealthEquity during the 3rd quarter worth $638,000. Vaughan Nelson Investment Management L.P. lifted its position in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Natixis Advisors LLC grew its stake in HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after buying an additional 48,009 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in HealthEquity by 29.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock valued at $5,535,000 after buying an additional 14,573 shares during the period. Finally, Diversify Wealth Management LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at approximately $8,182,000. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on HQY shares. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. JMP Securities restated a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Barrington Research reissued an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $107.23.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now owns 4,823 shares in the company, valued at $387,093.98. The trade was a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,536 shares of company stock worth $884,517. Company insiders own 2.20% of the company’s stock.

HealthEquity Trading Down 0.9 %

HQY opened at $101.54 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $105.82. The company’s 50 day moving average price is $90.16 and its two-hundred day moving average price is $82.81. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of 84.62, a PEG ratio of 1.59 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. As a group, research analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.